Update of the prostate, lung, colorectal, and ovarian cancer screening trial

Recent Results in Cancer Research

Volumn 202, Issue , 2014, Pages 53-57

  Andriole, Gerald L ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DIGITAL RECTAL EXAMINATION; HUMAN; INTERMETHOD COMPARISON; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SCREENING TEST; BODY MASS; COLORECTAL CANCER; COMORBIDITY; EDUCATION; FOLLOW UP; GLEASON SCORE; LUNG CANCER; MARRIAGE; OVARY CANCER; PHYSICAL ACTIVITY; PROSTATE BIOPSY; RACE; SMOKING; SURVIVAL RATE;

AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 84958553552     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-45195-9_6     Document Type: Article

References (8)

1. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; for the PLCO Project Team (2012) Prostate cancer screening in the randomized prostate, Lung, colorectal and ovarian cancer screening trial: mortality results after 13 years of followup. J Natl Cancer Inst. 104(2): 125-132. Epub 2012 Jan 6 PMID: 22228146
2. Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp GS, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; for the PLCO Project Team (2009) Mortality results from a prostate-cancer screening trial. NEJM 360: 1310-1319
3. Grubb, R.L., Pinksy, P.F., Greenlee, R.T., Izmirlian, G., Miller, A.B., Hickey, T.P., Riley, T.L., Mabie, J.E., Levin, D.L., Chia, D., Kramer, B.S., Reding, D.J., Church, T.R., Yokochi, L.A., Kvale, P.A., Weissfeld, J.L., Urban, D.A., Buys, S.S., Gelmann, E.P., Ragard, L.R., Crawford, E.D., Prorok, P.C., Gohagan, J.K., Berg, C.D., Andriole, G.L; for the PLCO Project Team (2008) Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU 102: 1524-1530
4. Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P, Gelmann E, Schoen RE, Buys S, Hayes RB, Berg CD (2007) Evidence of a healthy volunteer effect in the prostate lung, colorectal and ovarian cancer screening trial. Am J Epidemiol 165(8): 874-881
5. Pinsky PF, Black A, Kramer BS, Miller A, Prorok PC, Berg C (2010) Assessing contamination and compliance in the prostate component of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Clin Trials 7(4): 303-311
6. Pinsky PF, Black A, Parnes HL, Grubb R, Crawford ED, Miller A, Reding D, Andriole GL (2012) Prostate cancer specific survival in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Cancer Epidemiol 36(6):e401-e406 doi:10.1016/j.canep.2012.08.008. Epub 2012 Sep 19
7. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T (2012) Prostate cancer intervention versus observation trial (PIVOT) study group. N Engl J Med 367(3): 203-213. doi:10.1056/NEJMoa1113162.
8. Erratum in: N Engl J Med. 2012 Aug 9; 367(6): 582